BACKGROUND: In patients with atrial fibrillation (AF), the addition of surgical ablation to aortic valve replacement (AVR) does not increase procedural morbidity or mortality. However, efficacy in this population has not been carefully evaluated. This study compared outcomes between patients undergoing stand-alone Cox-Maze IV with those undergoing surgical ablation and concomitant AVR. METHODS: From January 2002 to May 2014, 188 patients received a stand-alone Cox-Maze IV (n = 113) or surgical ablation with concomitant AVR (n = 75). In the concomitant AVR group, patients underwent Cox-Maze IV (n = 58), left-sided Cox-Maze IV (n = 3), or pulmonary vein isolation (n = 14). Thirty-one perioperative variables were compared. Freedoms from AF on and off antiarrhythmic drugs were evaluated at 3, 6, 12, and 24 months. RESULTS: Follow-up was available in 97% of patients. Freedom from AF on and off antiarrhythmic drugs in patients receiving a stand-alone Cox-Maze IV versus concomitant AVR was not significantly different at any time point. The concomitant AVR group had more comorbidities, paroxysmal AF, pacemaker implantations (24% vs 5%, p = 0.002), and complications (25% vs 5%, p < 0.001). Freedoms from AF off antiarrhythmic drugs for patients receiving an AVR and pulmonary vein isolation at 1 year was only 50%, which was significantly lower than patients receiving an AVR and Cox-Maze IV ( 94%, p = 0.001). CONCLUSIONS: A Cox-Maze IV with concomitant AVR is as effective as a stand-alone Cox-Maze IV in treating AF, even in an older population with more comorbidities. Pulmonary vein isolation was not as effective and is not recommended in this population. A Cox-Maze IV should be considered in all patients undergoing AVR with a history of AF.
BACKGROUND: In patients with atrial fibrillation (AF), the addition of surgical ablation to aortic valve replacement (AVR) does not increase procedural morbidity or mortality. However, efficacy in this population has not been carefully evaluated. This study compared outcomes between patients undergoing stand-alone Cox-Maze IV with those undergoing surgical ablation and concomitant AVR. METHODS: From January 2002 to May 2014, 188 patients received a stand-alone Cox-Maze IV (n = 113) or surgical ablation with concomitant AVR (n = 75). In the concomitant AVR group, patients underwent Cox-Maze IV (n = 58), left-sided Cox-Maze IV (n = 3), or pulmonary vein isolation (n = 14). Thirty-one perioperative variables were compared. Freedoms from AF on and off antiarrhythmic drugs were evaluated at 3, 6, 12, and 24 months. RESULTS: Follow-up was available in 97% of patients. Freedom from AF on and off antiarrhythmic drugs in patients receiving a stand-alone Cox-Maze IV versus concomitant AVR was not significantly different at any time point. The concomitant AVR group had more comorbidities, paroxysmal AF, pacemaker implantations (24% vs 5%, p = 0.002), and complications (25% vs 5%, p < 0.001). Freedoms from AF off antiarrhythmic drugs for patients receiving an AVR and pulmonary vein isolation at 1 year was only 50%, which was significantly lower than patients receiving an AVR and Cox-Maze IV ( 94%, p = 0.001). CONCLUSIONS: A Cox-Maze IV with concomitant AVR is as effective as a stand-alone Cox-Maze IV in treating AF, even in an older population with more comorbidities. Pulmonary vein isolation was not as effective and is not recommended in this population. A Cox-Maze IV should be considered in all patients undergoing AVR with a history of AF.
Authors: Sunil M Prasad; Hersh S Maniar; Cindy J Camillo; Richard B Schuessler; John P Boineau; Thoralf M Sundt; James L Cox; Ralph J Damiano Journal: J Thorac Cardiovasc Surg Date: 2003-12 Impact factor: 5.209
Authors: Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin Journal: Heart Rhythm Date: 2007-04-30 Impact factor: 6.343
Authors: S Chris Malaisrie; Richard Lee; Jane Kruse; Brittany Lapin; Edward C Wang; Robert O Bonow; Patrick M McCarthy Journal: J Heart Valve Dis Date: 2012-05
Authors: Timo Weimar; Marci S Bailey; Yoshiyuki Watanabe; Donna Marin; Hersh S Maniar; Richard B Schuessler; Ralph J Damiano Journal: J Interv Card Electrophysiol Date: 2011-02-22 Impact factor: 1.900
Authors: Spencer J Melby; Andreas Zierer; Marci S Bailey; James L Cox; Jennifer S Lawton; Nabil Munfakh; Traves D Crabtree; Nader Moazami; Charles B Huddleston; Marc R Moon; Ralph J Damiano Journal: Ann Surg Date: 2006-10 Impact factor: 12.969
Authors: Ralph J Damiano; Sydney L Gaynor; Marci Bailey; Sunil Prasad; James L Cox; John P Boineau; Richard P Schuessler Journal: J Thorac Cardiovasc Surg Date: 2003-12 Impact factor: 5.209
Authors: Maciej Banach; Giovanni Mariscalco; Murat Ugurlucan; Dimitri P Mikhailidis; Marcin Barylski; Jacek Rysz Journal: Europace Date: 2008-10-01 Impact factor: 5.214
Authors: Jason O Robertson; Phillip S Cuculich; Lindsey L Saint; Richard B Schuessler; Marc R Moon; Jennifer Lawton; Ralph J Damiano; Hersh S Maniar Journal: Ann Thorac Surg Date: 2013-04-30 Impact factor: 4.330
Authors: Matthew R Schill; Farah N Musharbash; Vivek Hansalia; Jason W Greenberg; Spencer J Melby; Hersh S Maniar; Laurie A Sinn; Richard B Schuessler; Marc R Moon; Ralph J Damiano Journal: J Thorac Cardiovasc Surg Date: 2017-01-16 Impact factor: 5.209
Authors: Matthew C Henn; Timothy S Lancaster; Jacob R Miller; Laurie A Sinn; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano Journal: J Thorac Cardiovasc Surg Date: 2015-08-08 Impact factor: 5.209
Authors: Chawannuch Ruaengsri; Matthew R Schill; Ali J Khiabani; Richard B Schuessler; Spencer J Melby; Ralph J Damiano Journal: Eur J Cardiothorac Surg Date: 2018-04-01 Impact factor: 4.191
Authors: William L Patrick; Zehang Chen; Jason J Han; Benjamin Smood; Akhil Rao; Fabliha Khurshan; Siddharth Yarlagadda; Amit Iyengar; John J Kelly; Joshua C Grimm; Marisa Cevasco; Joseph E Bavaria; Nimesh D Desai Journal: Cardiol Ther Date: 2022-03-31
Authors: Camilla Skals Engelsgaard; Kenneth Bruun Pedersen; Lars Peter Riber; Peter Appel Pallesen; Axel Brandes Journal: Int J Cardiol Heart Vasc Date: 2018-04-13